HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Merkel cell carcer (MCC) is a rare and aggressive type of skin cancer that typically develops in the Merkel cells, which are located in the top layer of the skin. These cells are responsible for the sense of touch, making MCC distinct from other skin cancers. The exact cause of Merkel cell carcinoma is not fully understood, but it is often linked to exposure to ultraviolet (UV) radiation from the sun and other sources. Additionally, a weakened immune system, either due to aging, certain medical conditions, or immunosuppressive medications, is considered a risk factor for MCC. MCC usually presents as painless, firm, shiny nodules or lumps on the skin, often colored red, blue, or violet. While it can occur anywhere on the body, it is most commonly found on sun-exposed areas such as the head, neck, and limbs. Due to its rapid growth and potential to spread to other parts of the body, early detection and prompt treatment are crucial. Diagnosis involves a biopsy of the suspicious lesion, followed by various imaging tests to determine the extent of the cancer. Treatment options for Merkel cell carcinoma may include surgery to remove the tumor, radiation therapy, and in some cases, targeted therapy or immunotherapy. Given the rarity and aggressiveness of MCC, a multidisciplinary approach involving dermatologists, oncologists, and surgeons is often employed to provide comprehensive care. Prognosis varies depending on the stage at which the cancer is diagnosed, with early detection significantly improving the chances of successful treatment. As with many cancers, prevention includes sun protection measures such as using sunscreen, wearing protective clothing, and avoiding excessive UV exposure. Regular skin checks and prompt evaluation of any new or changing skin lesions are crucial in detecting Merkel cell carcinoma at an early and treatable stage.
